We demonstrated that, in contrast to classical opioid receptors, ACKR3 won't set off classical G protein signaling and is not modulated from the classical prescription or analgesic opioids, like morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists such as naloxone. Rather, we set up that LIH383, an ACKR3-selective https://elbertm379vrp3.dgbloggers.com/profile